KENNETH WEINBERG, MD
Medical Practice at Welch Rd, Palo Alto, CA
License number
California G55579
Category
Medical Practice
Type
Pediatric Hematology-Oncology
Address
Address
725 Welch Rd, Palo Alto, CA 94304
Phone
(650) 498-7103
Professional information
Kenneth Ivers Weinberg, Palo Alto CA
Specialties:
Pediatrics, Pediatric Hematology-Oncology, Surgery, Pediatric Surgery, Transplant Surgery, Hematology, Hematology, Hematology & Oncology, Medical Oncology
Work:
Stanford University
1000 Welch Rd, Palo Alto, CA 94304
1000 Welch Rd, Palo Alto, CA 94304
Education:
Stanford University (1978)
Dr. Kenneth Weinberg, Palo Alto CA - MD (Doctor of Medicine)
Specialties:
Pediatric Hematology & Oncology
Address:
1000 Welch Rd STE 300, Palo Alto 94304
(650) 497-8953 (Phone)
Lucille Pckrd Chldrn's Hospital PHO
725 Welch Rd, Palo Alto 94304
(650) 497-8953 (Phone)
(650) 497-8953 (Phone)
Lucille Pckrd Chldrn's Hospital PHO
725 Welch Rd, Palo Alto 94304
(650) 497-8953 (Phone)
Certifications:
Pediatric Oncology & Pediatric Hematology, 1984, Pediatrics, 1984
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
1000 Welch Rd STE 300, Palo Alto 94304
Lucille Pckrd Chldrn's Hospital PHO
725 Welch Rd, Palo Alto 94304
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
Lucille Pckrd Chldrn's Hospital PHO
725 Welch Rd, Palo Alto 94304
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
Education:
Medical School
Stanford University School Of Medicine
Graduated: 1978
Stanford University School Of Medicine
Graduated: 1978
Modulation Of Kit Signaling And Hematopoietic Cell Development By Il-4 Receptor Modulation
US Patent:
2012007, Mar 29, 2012
Filed:
Jul 12, 2011
Appl. No.:
13/135654
Inventors:
Atul J. Butte - Stanford CA, US
Kenneth Weinberg - Stanford CA, US
Maheswaran Mani - Sunnyvale CA, US
Kenneth Weinberg - Stanford CA, US
Maheswaran Mani - Sunnyvale CA, US
International Classification:
A61K 39/395, C12Q 1/02, C12Q 1/06, A61P 35/00, A61P 35/02, A61P 7/06, G01N 33/566, C12Q 1/68
US Classification:
4241581, 435 721, 435 29, 435 612, 435 39
Abstract:
Methods and compositions are provided for modulating Kit/stem cell factor receptor (SCFR)/CD117 and interleukin 4 receptor (IL-4R) signaling in a cell in vitro and in vivo, and for identifying candidate agents with activity in modulating Kit and IL-4R signaling. These methods find particular use in treating disorders of the hematopoietic system and in modulating hematopoietic stem cell expansion.